Search Results - "Wanders, S"

National consensus on biologic dose reduction in psoriasis: a modified eDelphi procedure by van der Schoot, L. S., Baerveldt, E. M., van Enst, W. A., Menting, S. P., Seyger, M. M. B., Wanders, S. L., van Ee, I., Pieterse, A. H., van den Reek, J. M. P. A., de Jong, E. M. G. J.

“…Dose reduction of biologics for psoriasis is applied in daily practice, although guidelines are lacking. Striving for clear criteria is important, as it leads…”
Get full text

OC-0129: Nitroglycerin decreases the hypoxic fraction of non-small cell lung cancer lesions by Reymen, B, Zegers, C.M.L, Van Elmpt, W, Mottaghy, F, Windhorst, A, Van Baardwjik, A, Wanders, S, Van Loon, J, De Ruysscher, D, Lambin, P

Get full text

Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study by de Rijke, J.M., Schouten, L.J., Velde, G.P.M.ten, Wanders, S.L., Bollen, E.C.M., Lalisang, R.I., Dijck, J.A.A.M.van, Kramer, G.W.P., Brandt, P.A.van den

“…Background: In the Netherlands in 1997, 43% of patients with newly diagnosed lung cancer were over 70. Large age-specific differences in treatment exist. We…”
Get full text

PD-0426: A clinical model predicting severe esophagitis in individual SCLC patients treated with chemo-radiotherapy by Reymen, B, Oberije, C, Van Loon, J, Van Baardwijk, A, Wanders, S, Troost, E, Hoebers, F, Zindler, J, Dingemans, A, Bootsma, G, Lunde, R, Geraedts, W, De Ruysscher, D, Lambin, P

Get full text

OC-0067: High dose re-irradiation prolongs survival in patients with recurrent lung cancer by Troost, E.G.C, Reymen, B, Van Baardwijk, A, Wanders, S, Hoebers, F.J.P, Bloemen-van Gurp, E.J, Smits, K.M, Dingemans, A.M, Lambin, P

Get full text

PO-0684: Clinical benefit of repeated CBCT imaging for evaluation of delivered dose during (chemo)radiotherapy in NSCLC by Egelmeer, A.G.T.M, Persoon, L.C.G.G, Nijsten, S, Ollers, M, Van Baardwijk, A, Wanders, S, Hoebers, F.J.P, Lambin, P, Verhaegen, F, Troost, E.G.C

Get full text

PD-0097: Impact of new Dutch guideline on patient selection for WBRT in a large lung cancer cohort by Hendriks, L, Steward, A, van Baardwijk, A, Reymen, B, Wanders, S, Bootsma, G, de Jaeger, K, van den Borne, B, Troost, E, Dingemans, A

Get full text

533 oral ADAPTIVE RADIOTHERAPY TREATMENT FOR PATIENTS WITH ATELECTASIS BASED ON PORTAL DOSIMETRY AND REPEATED CONEBEAM CT by Persoon, L, Öllers, M, Wanders, S, de Ruysscher, D, Tissen, D, Wouters, J, Verhaegen, F, Nijsten, S

Get full text

TARGET VOLUME DEFINITION FOR STAGE I NSCLC: SINGLE 4D CT SCAN VS. ONE STANDARD VS. SIX STANDARD CT SCANS by De Ruysscher, D, Bosmans, G, Öllers, M, Wanders, S, van Baardwijk, A, Reymen, B, Borger, J, Dekker, A, Lambin, P

Get full text

Time Trends in Nodal CT Volume and Nodal Motion During Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer by Bosmans, G, Boersma, L, van Baardwijk, A, Dekker, A, Oellers, M, Wanders, S, Lambin, P, De Ruysscher, D

Get full text

Osteopontin Level to Creatinine Clearance Predicts Survival of NSCLC Patients by Steck, H, Dehing, C, van der Weide, H, De Ruysscher, D, Nijsten, B, Wanders, S, Boersma, L, Krishnan, S, Rao, R.B, Lambin, P

Get full text

A Knowledge-Model for Predicting Radiation-Induced Esophagitis by Krishnapuram, B, Dehing, C, Steck, H, van der Weide, H, De Ruysscher, D, Nijsten, B, Wanders, S, Boersma, L, Rao, R.B, Lambin, P

Get full text

A prospective longitudinal study on radiation-induced hearing loss by Anteunis, L J, Wanders, S L, Hendriks, J J, Langendijk, J A, Manni, J J, de Jong, J M

“…Recent clinical reports indicate that patients receiving radiotherapy that includes the auditory system in the treatment volume are likely to develop an…”
Get more information

9108 Mature results of an individualized radiation dose prescription trial based on normal tissue constraints in stage I-III non-small cell lung cancer (NSCLC)(NCT00573040) by van Baardwijk, A, Wanders, S, Boersma, L, Bootsma, G, Pitz, C, Hochstenbag, M, Geraedts, W, Lunde, R, Lamin, P, De Ruysscher, D

Get full text

A handheld SPIO-based sentinel lymph node mapping device using differential magnetometry by Waanders, S, Visscher, M, Wildeboer, R R, Oderkerk, T O B, Krooshoop, H J G, Ten Haken, B

“…Sentinel lymph node biopsy has become a staple tool in the diagnosis of breast cancer. By replacing the morbidity-plagued axillary node clearance with removing…”
Get more information

919 POSTER FDG-PET based planning of limited stage small-cell lung cancer changes radiotherapy fields: a planning study by van Loon, J, De Ruysscher, D, Hochstenbag, M, Bootsma, G, Geraedts, W, Pitz, C, Simons, J, Dekker, A, Wanders, S, Lambin, P

Get full text

Docetaxel (Taxotere ), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study by STERNBERG, C. N, TEN BOKKEL HUININK, W. W, SMYTH, J. F, BRUNTSCH, V, DIRIX, L. Y, PAVLIDIS, N. A, FRANKLIN, H, WANDERS, S, LE BAIL, N, KAYE, S. B

“…Docetaxel (Taxotere), a new semisynthetic taxoid, is a potentially important chemotherapeutic agent for the treatment of cancer. Forty patients with…”
Get full text

Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study by De Ruysscher, Dirk, Wanders, Stofferinus, van Haren, Erik, Hochstenbag, Monique, Geeraedts, Wiel, Utama, Irwan, Simons, Jean, Dohmen, Jo, Rhami, Ali, Buell, Ulrich, Thimister, Paul, Snoep, Gabriel, Boersma, Liesbeth, Verschueren, Tom, van Baardwijk, Angela, Minken, Andre, Bentzen, Søren M, Lambin, Philippe

“…To evaluate the patterns of recurrence when selective mediastinal node irradiation based on FDG-PET scan data is used in patients with non-small-cell lung…”
Get more information

Single-dose radiotherapy (6 Gy): palliation in painful bone metastases by Uppelschoten, Jeroen M., Wanders, Stofferinus L., de Jong, Jos M.A.

“…Approximately 50% of patients with cancer develop bone metastases and these have an important influence on the quality of life. Purpose of the study. To…”
Get full text

Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens by BONASSI, S, HAGMAR, L, KNUDSEN, L. E, NORPPA, H, STROMBERG, U, MONTAGUD, A. H, TINNERBERG, H, FORNI, A, HEIKKILÄ, P, WANDERS, S, WILHARDT, P, HANSTEEN, I.-L

“…An increased risk of cancer in healthy individuals with high levels of chromosomal aberrations (CAs) in peripheral blood lymphocytes has been described in…”
Get full text